DXR — Daxor Corporation · P/E 6.5, rev $1.4M

Daxor Corporation (DXR) is a medical instruments & supplies company listed on US.

Latest reported DXR revenue for 2011-12-31 was $1.4M. Net income was -$7.2M. Revenue was down 8.4% from 2010-12-31 to 2011-12-31. DXR currently screens at market cap $61.9M and trailing P/E 6.5.

Use this DXR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the DXR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the DXR SEC filings page. Lician reads the product cache first so this HTML stays unique to Daxor Corporation even when a live quote feed is slow.